WPW
CVS icon

Waldron Private Wealth’s CVS Health CVS Stock Holding History

Waldron Private Wealth’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$429K Sell
4,150
-344
-8% -$30.7K 0.01% 245
2026
Q1 		$323K Buy
4,494
+34
+0.8% +$2.62K 0.01% 263
2025
Q4 		$354K Buy
4,460
+733
+20% +$57.8K 0.01% 245
2025
Q3 		$281K Hold
3,727
– – 0.01% 268
2025
Q2 		$257K Sell
3,727
-83
-2% -$5.44K 0.01% 270
2025
Q1 		$258K Sell
3,810
-3,536
-48% -$212K 0.01% 263
2024
Q4 		$330K Buy
7,346
+341
+5% +$19.1K 0.01% 315
2024
Q3 		$440K Buy
7,005
+622
+10% +$36.3K 0.02% 267
2024
Q2 		$377K Sell
6,383
-4,099
-39% -$256K 0.02% 278
2024
Q1 		$836K Buy
10,482
+237
+2% +$18.1K 0.04% 183
2023
Q4 		$809K Buy
10,245
+1,072
+12% +$76.3K 0.04% 180
2023
Q3 		$640K Sell
9,173
-1,151
-11% -$81.6K 0.03% 192
2023
Q2 		$714K Sell
10,324
-2,052
-17% -$146K 0.04% 188
2023
Q1 		$920K Buy
12,376
+1,239
+11% +$104K 0.04% 177
2022
Q4 		$1.06M Hold
11,137
– – 0.07% 149
2022
Q3 		$1.06M Buy
11,137
+405
+4% +$40.1K 0.07% 149
2022
Q2 		$994K Buy
10,732
+749
+8% +$73.1K 0.06% 168
2022
Q1 		$1.01M Sell
9,983
-988
-9% -$104K 0.05% 181
2021
Q4 		$1.13M Buy
10,971
+180
+2% +$16.6K 0.06% 164
2021
Q3 		$915K Buy
10,791
+769
+8% +$64.4K 0.05% 161
2021
Q2 		$836K Sell
10,022
-637
-6% -$52.2K 0.05% 155
2021
Q1 		$801K Sell
10,659
-82
-0.8% -$5.97K 0.06% 144
2020
Q4 		$733K Sell
10,741
-347
-3% -$22.6K 0.05% 149
2020
Q3 		$647K Buy
11,088
+678
+7% +$42.2K 0.06% 143
2020
Q2 		$676K Buy
10,410
+863
+9% +$54.3K 0.06% 136
2020
Q1 		$566K Buy
9,547
+73
+0.8% +$4.87K 0.06% 135
2019
Q4 		$703K Sell
9,474
-650
-6% -$45.6K 0.06% 139
2019
Q3 		$638K Buy
10,124
+940
+10% +$55.7K 0.07% 138
2019
Q2 		$500K Sell
9,184
-679
-7% -$36.6K 0.05% 138
2019
Q1 		$531K Buy
9,863
+2,252
+30% +$139K 0.06% 139
2018
Q4 		$498K Buy
7,611
+1,145
+18% +$85.5K 0.07% 121
2018
Q3 		$509K Buy
6,466
+1,673
+35% +$120K 0.1% 99
2018
Q2 		$308K Buy
4,793
+77
+2% +$5.07K 0.07% 132
2018
Q1 		$293K Buy
4,716
+70
+2% +$5.02K 0.07% 130
2017
Q4 		$336K Buy
4,646
+158
+4% +$11.5K 0.08% 113
2017
Q3 		$364K Buy
4,488
+825
+23% +$65.3K 0.1% 94
2017
Q2 		$294K Sell
3,663
-6,970
-66% -$550K 0.09% 96
2017
Q1 		$835K Buy
10,633
+7,283
+217% +$581K 0.21% 65
2016
Q4 		$264K Buy
3,350
+1,003
+43% +$81.2K 0.09% 104
2016
Q3 		$208K Sell
2,347
-2,643
-53% -$249K 0.08% 133
2016
Q2 		$477K Buy
4,990
+2,273
+84% +$227K 0.18% 64
2016
Q1 		$281K Sell
2,717
-165
-6% -$16K 0.11% 102
2015
Q4 		$281K Sell
2,882
-38
-1% -$3.72K 0.1% 111
2015
Q3 		$281K Sell
2,920
-808
-22% -$84.9K 0.12% 89
2015
Q2 		$354K Buy
3,728
+795
+27% +$81.2K 0.14% 65
2015
Q1 		$303K Sell
2,933
-114
-4% -$11.5K 0.12% 66
2014
Q4 		$293K Sell
3,047
-499
-14% -$44K 0.12% 76
2014
Q3 		$282K Sell
3,546
-413
-10% -$32.6K 0.13% 67
2014
Q2 		$298K Sell
3,959
-587
-13% -$44.4K 0.14% 74
2014
Q1 		$340K Sell
4,546
-3
-0.1% -$212 0.17% 56
2013
Q4 		$326K Buy
+4,549
New +$292K 0.15% 59

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Waldron Private Wealth's CVS Position: Q2 2026 in Review

Waldron Private Wealth reduced its CVS Health (CVS) stake by 7.7% in Q2 2026, selling an estimated $30.7K and leaving 4,150 shares worth $429K. The position accounts for 0.01% of the portfolio, ranked #245.

Waldron Private Wealth first reported a position in CVS in Q4 2013 and has held it in 51 quarters since. The position peaked at $1.13M in Q4 2021. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Waldron Private Wealth held 4,150 shares of CVS Health worth $429K as of Q2 2026.
  • Waldron Private Wealth sold 344 CVS Health shares in Q2 2026, an estimated $30.7K.
  • CVS Health made up 0.01% of Waldron Private Wealth's portfolio in Q2 2026, its #245 holding.
  • Waldron Private Wealth first reported a position in CVS Health in Q4 2013 and has held it in 51 quarters since.
  • Waldron Private Wealth's CVS Health position peaked at $1.13M in Q4 2021.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Waldron Private Wealth's 13F filing for Q2 2026, filed 20 Jul 2026.